CT prediction of resectability and prognosis in patients with pancreatic ductal adenocarcinoma after neoadjuvant treatment using image findings and texture analysis
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Bo Ram | - |
dc.contributor.author | Kim, Jung Hoon | - |
dc.contributor.author | Ahn, Su Joa | - |
dc.contributor.author | Joo, Ijin | - |
dc.contributor.author | Choi, Seo-Youn | - |
dc.contributor.author | Park, Sang Joon | - |
dc.contributor.author | Han, Joon Koo | - |
dc.date.accessioned | 2021-08-11T10:24:06Z | - |
dc.date.available | 2021-08-11T10:24:06Z | - |
dc.date.issued | 2019-01 | - |
dc.identifier.issn | 0938-7994 | - |
dc.identifier.issn | 1432-1084 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/4839 | - |
dc.description.abstract | ObjectivesTo assess utility of CT findings and texture analysis for predicting the resectability and prognosis in patients after neoadjuvant therapy for pancreatic ductal adenocarcinoma (PDAC).Materials and methodsAmong 308 patients, 45 with PDAC underwent neoadjuvant therapy (concurrent-chemoradiation-therapy, CCRT, n = 27 and chemotherapy, ChoT, n = 18) before surgery were included. All underwent baseline and preoperative CT. Two reviewers assessed CT findings and resectability. We analyzed relationship between CT resectability and residual tumor. CT texture values obtained by subtracting preoperative from baseline CT were analyzed using multivariate Cox/logistic regression analysis to identify significant parameters predicting resectability and prognosis.ResultsThere were 30 patients without residual tumor (CCRT, n = 20; ChoT, n = 10) and 15 with residual tumor (CCRT, n = 7; ChoT, n = 8). Considering borderline as resectable was more accurate for R0 resectability than considering borderline as unresectable (68.9% vs 55.6% and 51.1%, p < 0.001). Particularly, neoadjuvant CCRT provided better accuracy than that in (p < 0.001). In CT texture analysis, higher subtracted entropy (cut-off: 0.03, HR 0.159, p = 0.005) and lower subtracted GLCM entropy (cut-off: -0.35, HR 10.235, p = 0.036) are important parameters for prediction of longer overall survival.ConclusionCT findings with texture analysis can be useful for predicting a patient's outcome, including resectability and prognosis, after neoadjuvant therapy for PDAC.Key Points center dot Considering borderline resectable tumor as resectable have better accuracy for resectability.center dot Considering borderline as resectable, CCRT-patients have better resectability accuracy than chemotherapy-patients.center dot Higher subtracted entropy and lower subtracted GLCM entropy are predictors of favorable outcome. | - |
dc.format.extent | 11 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | Springer Verlag | - |
dc.title | CT prediction of resectability and prognosis in patients with pancreatic ductal adenocarcinoma after neoadjuvant treatment using image findings and texture analysis | - |
dc.type | Article | - |
dc.publisher.location | 미국 | - |
dc.identifier.doi | 10.1007/s00330-018-5574-0 | - |
dc.identifier.scopusid | 2-s2.0-85048777716 | - |
dc.identifier.wosid | 000453471200043 | - |
dc.identifier.bibliographicCitation | European Radiology, v.29, no.1, pp 362 - 372 | - |
dc.citation.title | European Radiology | - |
dc.citation.volume | 29 | - |
dc.citation.number | 1 | - |
dc.citation.startPage | 362 | - |
dc.citation.endPage | 372 | - |
dc.type.docType | Article | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | sci | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Radiology, Nuclear Medicine & Medical Imaging | - |
dc.relation.journalWebOfScienceCategory | Radiology, Nuclear Medicine & Medical Imaging | - |
dc.subject.keywordPlus | CONTRAST-ENHANCED CT | - |
dc.subject.keywordPlus | CANCER HETEROGENEITY | - |
dc.subject.keywordPlus | TUMOR HETEROGENEITY | - |
dc.subject.keywordPlus | CHEMOTHERAPY | - |
dc.subject.keywordPlus | RESECTION | - |
dc.subject.keywordPlus | THERAPY | - |
dc.subject.keywordPlus | CHEMORADIATION | - |
dc.subject.keywordPlus | REASSESSMENT | - |
dc.subject.keywordPlus | CARCINOMA | - |
dc.subject.keywordPlus | BIOMARKER | - |
dc.subject.keywordAuthor | Pancreatic neoplasm | - |
dc.subject.keywordAuthor | Neoadjuvant therapy | - |
dc.subject.keywordAuthor | Pancreatectomy | - |
dc.subject.keywordAuthor | Prognosis | - |
dc.subject.keywordAuthor | Diagnosis | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(31538) 22, Soonchunhyang-ro, Asan-si, Chungcheongnam-do, Republic of Korea+82-41-530-1114
COPYRIGHT 2021 by SOONCHUNHYANG UNIVERSITY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.